CMT 1A Patients - Join the Ascorbic Acid Trial!

The CMT Team
From left to right: Carly Siskind, MS; Shawana Feely, MS; Soham Sheth, MD; Rosemary Shy, MD; Michael Shy, MD; Kevin Francies; George Trigge; & Richard Lewis, MD
Not Pictured: Jun Li, MD, PhD; Agnes Acsadi, MD; Guyla Acsadi, MD; Steven Hinderer, MD; & Lisa Rowe
|
What is Charcot-Marie-Tooth
disease (CMT)?
|
|
|
|
Charcot-Marie-Tooth disease (CMT),
named for the three doctors who described the condition in the late 1800's,
is one of the most common inherited neurological conditions. About one in
2,500 people have CMT. CMT first affects the lower legs and feet leading to
weakness, numbness, and sometimes changes in the shape of the foot. As the
condition progresses, weakness and numbness can also occur in the hands and
forearms. CMT does not affect a person's intelligence and is not associated
with a shortened life span. |
|
|
|
Address
and Phone numbers: |
|
|
|
Clinic: |
|
|
|
Choose from the links on the left
to learn more about the CMT clinic and CMT research at Wayne State
University. |